MedTrace Logo

Screening Protocol for HIV Vaccine Studies

NCT00031304 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1324

Last updated 2019-12-05

No results posted yet for this study

Summary

Healthy volunteers will be screened under this protocol for possible participation in a study testing a vaccine against HIV, the virus that causes AIDS.

Healthy adults 18 to 60 years of age may be eligible for this study. Participants must be in good general health with no history of significant medical problems or abnormal laboratory test results. Pregnant or breast-feeding women and people infected with HIV will not be enrolled.

Participants enrolled in this protocol will undergo the following tests and procedures within 8 weeks before the start of the experimental vaccine study:

* Medical history, including history of sexual activity and drug use
* Physical examination
* Pregnancy test for women of childbearing age
* Blood and urine tests to evaluate possible medical problems such as liver and kidney function; to evaluate immune function; and to test for HIV, hepatitis and syphilis

Individuals who are identified through this screening protocol as possible candidates for an HIV vaccine trial will be provided additional information about study options.

Conditions

  • HIV Seronegativity
  • HIV Infections

Sponsors & Collaborators

  • National Institute of Allergy and Infectious Diseases (NIAID)

    lead NIH

Principal Investigators

  • Barney S Graham, M.D. · National Institute of Allergy and Infectious Diseases (NIAID)

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2002-02-27
Completion
2013-04-08

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00031304 on ClinicalTrials.gov